|
|
|
Corporate Profile: Cobalis
| Summary: |
| Cobalis’
current research is focused on studying the effects
of cyanocobalamin on the reduction of symptoms associated
with seasonal and perennial allergic rhinitis. Following
successful commercialization of cyanocobalmin, they
plan to sponsor clinical trials into other immunoglobulin-E
(IgE)-mediated allergic diseases. |
| Address: |
2445 McCabe Way
Suite 150
Irvine, CA 92614 |
| Phone
#'s: |
| Main |
(949) 757-0001 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s: |
| Main |
(949) 757-0979 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Internet
job postings: |
| not
known |
| Patent
position: |
| U.S.
patents: 1976-present: patent
link. |
|
|
|
